Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases.
Amgen Inc. is an American multinational biopharmaceutical company that discovers, develops, manufactures, and delivers innovative biologic medicines to treat serious illnesses, including cancer, cardiovascular disease, osteoporosis, inflammatory and rare diseases.
Indegene Limited is a digital-first company focused on life sciences commercialization, serving the biopharmaceutical, emerging biotech, and medical device industries. The company assists healthcare organizations in developing products, bringing them to market, and maximizing their impact throughout the product lifecycle.
With over 5,000 employees across 17 offices globally, Indegene supports 63 active clients, including 20 of the top 20 global biopharmaceutical companies. The company offers a range of digital-led commercialization solutions, including analytics, technology, commercial, medical, regulatory, and safety services, as well as an omnichannel business segment.
Indegene has shown strong financial growth, with revenues expanding at a CAGR of 31.1% over the past decade. The company is listed on the BSE and NSE and aims to be a trusted partner for healthcare organizations, helping them achieve improved health outcomes and prepare for the future.